November 11, 2018, 08:03 GMT Fresenius Medical Care was listed on its home market at Xetra for € 71.09. The company is part of the Health Services segment.
To evaluate this course, we conducted the multi-step analysis method of the Fresenius Medical Care program. This leads to estimates of whether Fresenius Medical Care should be classified as "buy", "hold" or "sell". The final consolidation of these estimates gives an overall rating.
1. Industry comparison Share price: Earnings per share were -16.38 per cent last year. Fresenius Medical Care is 27.1 percent less than the average (10.72 percent) of the shares in the same sector ("Health Care"). In the same industry, the average annual return on "Health Care Facilities & Svcs" securities is 16.73 percent. Fresenius Medical Care is currently 33.11 percent below this level. Due to the low performance we criticize the full extent at this level of "selling".
2. Sentiment and Buzz: Fresenius Medical Care can also be detected and evaluated for a longer period of time by the amount of oral statements (conversational intensity) and mood change. This leads to interesting conclusions about the long-term vision of recent months. In particular: There is little activity in the store. This means average discussion under discussion and requires a "sell" rating. The volume change was pretty good, a positive change could be identified, which corresponds to the "buy" rating. In the general classification, the Fresenius Medical Care rating for this item is "Buy".
3. Relative Strength Index: The Relative Strength Index (RSI) relates to Time Backward and Downward Movement over time, so it is a good indicator of whether or not the stock is up or down. The value of the last 7 days of RSI in Fresenius Medical Care is 44.88. Based on this, the stock does not have overcapacity and does not sell and it gets the "Hold" value. It is now comparing the 7-day RSI value with RSI for 25 days (71.3). RSI25 is 71.3, which means that Fresenius Medical Care is overbold here, unlike RSI7. Security is therefore exceptionally classified as "sell". Overall, RSI appreciation leads to the sale of Fresenius Medical Care product.